ovarian function suppression

Best

Treatment in HR+ Early Breast Cancer May be Best Guided by Risk of Recurrence

William J. Gradishar, MD, FASCO, FACP After settling the debate of which patients with early-stage, hormone receptor–positive breast cancer require…